denkapparat Operations’s BioMarin Pharmaceuticals BMRN Stock Holding History

denkapparat Operations’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$674K	Sell	11,938 -1,886	-14%	-$110K	0.28%	138
2025 Q4	$822K	Buy	13,824 +2,756	+25%	+$150K	0.45%	77
2025 Q3	$599K	Buy	11,068 +3,442	+45%	+$197K	0.38%	98
2025 Q2	$419K	Buy	7,626 +500	+7%	+$29.4K	0.33%	120
2025 Q1	$504K	Buy	+7,126	New	+$479K	0.53%	67

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

denkapparat Operations's BMRN Position: Q1 2026 in Review

denkapparat Operations reduced its BioMarin Pharmaceuticals (BMRN) stake by 14% in Q1 2026, selling an estimated $110K and leaving 11,938 shares worth $674K. The position accounts for 0.28% of the portfolio, ranked #138.

denkapparat Operations first reported a position in BMRN in Q1 2025 and has held it in 5 quarters since. The position peaked at $822K in Q4 2025. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

denkapparat Operations held 11,938 shares of BioMarin Pharmaceuticals worth $674K as of Q1 2026.
denkapparat Operations sold 1,886 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $110K.
BioMarin Pharmaceuticals made up 0.28% of denkapparat Operations's portfolio in Q1 2026, its #138 holding.
denkapparat Operations first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
denkapparat Operations's BioMarin Pharmaceuticals position peaked at $822K in Q4 2025.
554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.